Hetaryl imidazoles: a novel dual inhibitors of VEGF receptors I and II.

Article Details

Citation

Copy to clipboard

Kiselyov AS, Semenova M, Semenov VV, Piatnitski E, Ouyang S

Hetaryl imidazoles: a novel dual inhibitors of VEGF receptors I and II.

Bioorg Med Chem Lett. 2006 Mar 1;16(5):1440-4.

PubMed ID

16321531 [ View in PubMed

]

Abstract

A novel potent derivatives of hetaryl imidazoles were described as inhibitors of vascular endothelial growth factor receptor II (VEGFR-2). Several compounds display VEGFR-2 inhibitory activity reaching IC(50)<100 nM in both enzymatic and cellular assays. The compounds also inhibit the related tyrosine kinase, VEGFR-1. By controlling the substitution pattern on the 5-carboxamido functionality, both dual and specific VEGFR-2 thiazoles were identified.

DrugBank Data that Cites this Article

Binding Properties

Drug	Target	Property	Measurement	pH	Temperature (°C)
Vatalanib	Vascular endothelial growth factor receptor 1	IC 50 (nM)	140	N/A	N/A	Details
Vatalanib	Vascular endothelial growth factor receptor 2	IC 50 (nM)	54	N/A	N/A	Details
Vatalanib	Vascular endothelial growth factor receptor 2	IC 50 (nM)	21	N/A	N/A	Details